Zorica P. Cvetkovic

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Identification and management of sarcopenia in patients with multimorbidity: An EFIM critically appraised and adapted guideline.

Identification and management of sarcopenia in patients with multimorbidity: An EFIM critically appraised and adapted guideline.

Journal: European journal of internal medicine

Published: June 07, 2026

Analysis of Prognostic Significance of CD47 Expression in Newly Diagnosed Large B Cell Lymphoma.

Analysis of Prognostic Significance of CD47 Expression in Newly Diagnosed Large B Cell Lymphoma.

Journal: Life (Basel, Switzerland)

Published: March 30, 2026

Plasma expression of long non-coding RNA GAS5 and its prognostic significance in newly diagnosed multiple myeloma.

Plasma expression of long non-coding RNA GAS5 and its prognostic significance in newly diagnosed multiple myeloma.

Journal: Frontiers in oncology

Published: January 19, 2026

Prognostic Value of the CALLY Index in Diffuse Large B-Cell Lymphoma: Linking Inflammation, Nutrition, and Tumor Biology.

Prognostic Value of the CALLY Index in Diffuse Large B-Cell Lymphoma: Linking Inflammation, Nutrition, and Tumor Biology.

Journal: Cancers

Published: January 18, 2026

Tumor Microenvironment, Inflammation, and Inflammatory Prognostic Indices in Diffuse Large B-Cell Lymphomas: A Narrative Review.

Tumor Microenvironment, Inflammation, and Inflammatory Prognostic Indices in Diffuse Large B-Cell Lymphomas: A Narrative Review.

Journal: International journal of molecular sciences

Published: May 18, 2025

Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group.

Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group.

Journal: Clinical lymphoma, myeloma & leukemia

Published: November 18, 2024

Metabolic Reprogramming of Phospholipid Fatty Acids as a Signature of Lung Cancer Type.

Metabolic Reprogramming of Phospholipid Fatty Acids as a Signature of Lung Cancer Type.

Journal: Cancers

Published: September 06, 2024

Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG).

Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG).

Journal: Leukemia & lymphoma

Published: August 14, 2024

Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review.

Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review.

Journal: International journal of molecular sciences

Published: July 14, 2024

VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG).

VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG).

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 20, 2024

The Role of the Spleen and the Place of Splenectomy in Autoimmune Hemolytic Anemia-A Review of Current Knowledge.

The Role of the Spleen and the Place of Splenectomy in Autoimmune Hemolytic Anemia-A Review of Current Knowledge.

Journal: Diagnostics (Basel, Switzerland)

Published: July 31, 2023

Disturbed Plasma Lipidomic Profiles in Females with Diffuse Large B-Cell Lymphoma: A Pilot Study.

Disturbed Plasma Lipidomic Profiles in Females with Diffuse Large B-Cell Lymphoma: A Pilot Study.

Journal: Cancers

Published: April 18, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026